Degeneration of rabbit sensory neurons induced by passive transfer of anti-GD1b antiserum

Neuroscience Letters

Volumn 273, Issue 1, 1999, Pages 33-36

  Kusunoki, Susumu ^a   Hitoshi, Seiji ^a   Kaida, Ken Ichi ^b   Murayama, Shigeo ^a   Kanazawa, Ichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Ataxia; Autoimmune; Ganglioside; GD1b; Glycolipid; Neuropathy; Sensory neuron

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA; AUTOIMMUNE DISEASE; CONTROLLED STUDY; HISTOLOGY; NERVE DEGENERATION; NEUROPATHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RABBIT; SENSORY NERVE CELL;

ANIMALS; ATAXIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; GANGLIOSIDES; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; MACROPHAGES; NERVE DEGENERATION; NEURONS, AFFERENT; RABBITS; VACUOLES;

EID: 0032835428     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00621-7     Document Type: Article

References (20)

1. Chiba A., Kusunoki S., Shimizu T., Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31:1992;677-679.
2. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 43:1993;1911-1917.
3. Daune G.C., Farrer R.G., Dalakas M.C., Quarles R.H. Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioiside. Ann. Neurol. 31:1992;683-685.
4. Hartung H.P., Pollard J.D., Harvey G.K., Toyka K.V. Immunopathogenesis and treatment of the Guillain-Barré syndrome- part I. Muscle Nerve. 18:1995;137-153.
5. Hitoshi S., Kusunoki S., Tsuji S., Kanazawa I. Rabbit experimental sensory ataxic neuropathy: anti-GD1b antibody-mediated trkC downregulation of dorsal root ganglia neurons. Neurosci. Lett. 260:1999;157-160.
6. Horwich M.S., Cho L., Porro R.S., Posner J.B. Subacute sensory neuropathy: a remote effect of carcinoma. Ann. Neurol. 2:1977;7-19.
7. Ilyas A.A., Quarles R.H., Dalakas M.C., Fishman P.H., Brady R.O. Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups. Ann. Neurol. 18:1985;655-659.
8. Ilyas A.A., Willison H.J., Quarles R.H., Jungalwala F.B., Cornblath D.R., Trapp B.D., Griffin D.E., Griffin J.W., McKhann G.M. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann. Neurol. 23:1988;440-447.
9. Kusunoki S., Chiba A., Tai T., Kanazawa I. Localization of GM1 and GD1b antigens in the human peripheral nervous system. Muscle Nerve. 16:1993;752-756.
10. Kusunoki S., Chiba A., Kon K., Ando S., Arisawa K., Tate A., Kanazawa I. N-Acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann. Neurol. 35:1994;570-576.
11. Kusunoki S., Shimizu J., Chiba A., Ugawa Y., Hitoshi S., Kanazawa I. Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann. Neurol. 39:1996;424-431.
12. Kusunoki S., Mashiko H., Mochizuki N., Chiba A., Arita M., Hitoshi S., Kanazawa I. Binding of antibodies against GM1 and GD1b in human peripheral nerve. Muscle Nerve. 20:1997;840-845.
13. Kusunoki S., Hitoshi S., Kaida K., Arita M., Kanazawa I. Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy. Ann. Neurol. 45:1999;400-403.
14. Oga T., Kusunoki S., Fujimura H., Kuboki T., Yoshida T., Takai T. Severe motor-dominant neuropathy with IgM M-protein binding to the NeuAcα2-3Galβ-moiety. J. Neurol. Sci. 154:1998;4-7.
15. Pestronk A., Choksi R. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Neurology. 49:1997;1289-1292.
16. Rees J.H., Gregson N.A., Hughes R.A.C. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann. Neurol. 38:1995;809-816.
17. Reiber H., Suckling A.J., Rumsby M.G. The effect of Freund's adjuvants on blood-cerebrospinal fluid barrier permeability. J. Neurol. Sci. 63:1984;55-61.
18. Sadiq S.A., Thomas F.P., Kilidireas K., Protopsaltis S., Hays A.P., Lee K.W., Romas S.N., Kumar N., van den Berg L., Santoro M., Lange D.J., Younger D.S., Lovelace R.E., Trojaborg W., Sherman W.H., Miller J.R., Minuk J., Fehr M.A., Roelofs R.I., Hollander D., Nichols F.T. III, Mitsumoto H., Kelley J.J. Jr, Swift T.R., Munsat T.L., Latov N. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology. 40:1990;1067-1072.
19. Thornton C.A., Griggs R.C. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann. Neurol. 35:1994;260-268.
20. Willison H.J., Paterson G., Veitch J., Inglis G., Barnett S.C. Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins. J. Neurol. Neurosurg. Psychiatry. 56:1993;1178-1183.